Detalhe da pesquisa
1.
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in Italy.
Oncologist
; 28(12): e1179-e1184, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37699107
2.
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Clin Cancer Res
; 29(17): 3429-3437, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37417941
3.
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
NPJ Breast Cancer
; 8(1): 66, 2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595761